Cyclerion Therapeutics logo
Cyclerion Therapeutics CYCN
$ 3.14 6.58%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Cyclerion Therapeutics Income Statement 2011-2024 | CYCN

Annual Income Statement Cyclerion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

6.78 M 1.13 M 41.1 M 101 M 93.1 M - - - - - - - -

Shares

2.34 M 2.17 M 39.1 M 32.1 M 27.4 M - - - - - - - -

Historical Prices

2.9 0.52 1.05 3.84 4.28 - - - - - - - -

Net Income

-5.26 M -44.1 M -51.6 M -77.8 M -123 M -115 M -93.9 M - - - - - -

Revenue

- 297 K 3.94 M 2.3 M 4.51 M - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - 2.3 M - - - - - - - - -

Operating Income

-13 M -18.5 M -55.2 M -81.3 M -125 M -115 M - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

- -18.5 M -54.7 M -79 M -122 M -114 M -92.2 M - - - - - -

Operating Expenses

13 M 18.8 M 59.1 M 85.2 M 130 M - - - - - - - -

General and Administrative Expenses

8.13 M 12.9 M 20.6 M 28.8 M 34.4 M 27.5 M 15.1 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Cyclerion Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

2.53 M 2.51 M 2.49 M 2.47 M 2.44 M 2.28 M 2.18 M 2.18 M 2.17 M 2.17 M 43.4 M 43.4 M 43.3 M 35.7 M 34.1 M 34 M 32.1 M 27.8 M 27.7 M 27.6 M 27.4 M 27.4 M 27.4 K - 27.4 K 27.4 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-723 K -1.32 M -1.54 M - 7.57 M -4.18 M -6.95 M - -10.5 M -13.4 M -13 M - -11.3 M -16.2 M -13.4 M - -18.8 M -19.5 M -20.2 M - -27.3 M -32.3 M -37.4 M - -29.3 M -29.8 M -25.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

194 K - - - - - - - - 306 K 711 K - 348 K 3 M 62 K - 400 K 749 K 1.01 M - 1.4 M 1.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-1.13 M -1.38 M -1.62 M - -6.02 M -1.86 M -3.28 M - -4.52 M -13.4 M -13 M - -11.3 M -16.2 M -13.4 M - -21.8 M -19.7 M -20.6 M - -28 M -33.1 M -37.4 M - -29.3 M -29.8 M -25.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - -4.45 M -13.4 M -12.9 M - -10.9 M -15.8 M -13.1 M - -21.2 M -19.1 M -20 M - -27.3 M -32.3 M -36.9 M - -28.9 M -29.4 M -24.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

1.32 M 1.38 M 1.62 M - 6.02 M 2.4 M 3.28 M - 4.52 M 13.7 M 13.7 M - 11.6 M 19.2 M 13.5 M - 22.2 M 20.4 M 21.6 M - 29.4 M 34.7 M 37.4 M - 29.3 M 29.8 M 25.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

1.24 M 1.28 M 1.57 M - 2.13 M 1.53 M 2.7 M - 3.1 M 3.52 M 3.95 M - 4.6 M 6.24 M 5.36 M - 8.03 M 6.63 M 6.89 M - 7.12 M 8.92 M 11 M - 7.79 M 7.53 M 3.77 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency